"
Team:NYMU-Taipei/Project
From 2010.igem.org
(→Safety Issues) |
|||
| Line 28: | Line 28: | ||
** Fast, specific, and constitutive proteolysis achieved by engineering fluorescent proteins with LVA tags. | ** Fast, specific, and constitutive proteolysis achieved by engineering fluorescent proteins with LVA tags. | ||
| - | = Safety Issues= | + | = <font color=blue>Safety Issues= |
Here we detail how we approached any issues of biological safety associated with our projects. | Here we detail how we approached any issues of biological safety associated with our projects. | ||
| Line 52: | Line 52: | ||
We also documented all our answers to these safety questions in our presentation, wiki presentation, and poster. | We also documented all our answers to these safety questions in our presentation, wiki presentation, and poster. | ||
| - | |||
= <font color=blue>Acknowledgements</font> = | = <font color=blue>Acknowledgements</font> = | ||
Revision as of 15:02, 27 October 2010
| Home | Project Overview | Speedy reporter | Speedy switch | Speedy protein degrader | Experiments and Parts | Applications | F.A.Q | About Us |
Contents |
Project overview by animation
Motivation
Our motivation arised from the following emergent needs in the development of synthetic biology:
- Detailed design rules for large-scale genetic circuit design.
- Comprehensive information of the interactions among genetic parts in vivo.
- Exploring gene expression mechanisms using traditional methods takes too much time.
The biobrick parts registry is beginning to overflow with parts. However, every team that has used information from parts registry knows how complex it is. Even if we follow the correct arrangement of parts (i.e. regulator-RBS-coding sequence-terminator), some parts just won’t work together in a large circuit design. Current iGEM teams are favor to do a big project which has a complex circuit design. However, these excellent projects almost turn out to be just design withnot much successful experimental results ultimately. So much time is wasted trying to guess blindly at which parts/devices can interact together, and which parts/devices cannot. There are definitely needs of detailed rules for large-scale circuit design and for the future development of synthetic biology.
With this in mind, we are interested in more specific design rules of a genetic circuit. We want to look closely at the central dogma, and more specifically, at the mRNA level.
Traditionally, we find out if the circuits we made are working or not by looking at the expression of reporter genes, but it would be a lot better if we could have quantitative descriptions of gene expression in both space and time. Base on the detailed information of gene expression, we can know about the interactions between biological parts in vivo. However, studying the gene expression mechanism using traditional methods takes too much time. To reduce the needed time of dealing with this kind of problem we have come up with our project: SpeedyBac.
Overview
For iGEM2010, the NYMU-Taipei team has created a novel assaying system ("SpeedyBac") that can
- speed up the expression detection of a gene flow.
- reveal the location and quantity of both mRNAs and Proteins.
- Between the mRNA level and protein level of our gene expression cycle, we have integrated a riboswitch that allows us to stop, start and control the translation of proteins. Using this switch, we can study mRNA and its protein(s) in one cycle without the interference of one or the other.
- the speedy degradation device we built can stop the gene expression quickly and cleanly.
Design
To achieve our goal, our SpeedyBac system is designed with the following three devices:
- Speedy switch
- Controls and speeds up mRNA translation into protein via a riboswitch between mRNA and protein level of gene expression.
- Speedy reporter
- Using mRNA aptamers and split GFP-eIF4A reporter systems to quickly outperform promoter-only activity.
- Speedy protein degrader
- Fast, specific, and constitutive proteolysis achieved by engineering fluorescent proteins with LVA tags.
Safety Issues
Here we detail how we approached any issues of biological safety associated with our projects.
Specifically, the following four questions were considered:
- Would any of our project ideas raise safety issues in terms of:
- researcher safety,
- public safety, or
- environmental safety?
- Is there a local biosafety group, committee, or review board at our institution?
- What does our local biosafety group think about our project?
- Do any of the new BioBrick parts that we made this year raise any safety issues?
- If yes, did we document these issues in the Registry?
Our answers to these four questions:
- For iGEM 2009 project, our goal is to design and engineer bacteria (called "ViroCatcher") to bind and remove many kinds of viruses. However, due to potential safety issues of using viral particles in our experiments, we only used viral proteins in our experiments to prove the concept. Although these viral proteins we used are viral capsid proteins for binding to huamn cellular receptors, they are neither toxic nor pathogenic by themselves. These viral capsid proteins or even viral paticles are not able to replicate in the bacterial chassis we used for making ViroCatcher. Therefore, they should not raise safety issues in terms of:
- researcher safety,
- public safety, or
- environmental safety.
- At NYMU, we do have a biosafety committee to review all biosafety and biosecurity issues at our university.
- We had presented our ViroCatcher project to many of our school professors including many of the members of our biosafety committee. Since we were not using viral particles or viral vectors in any of our experiments, they did not think the use of viral capsid proteins in our project would raise any biosafety issues.
- None of the new BioBrick parts that we made this year raise any safety issues. Since we are not authorized to give out those gene clones of viral capsid proteins, all those clones are not shipped as new BioBrick parts at this time.
We also documented all our answers to these safety questions in our presentation, wiki presentation, and poster.
Acknowledgements
We are grateful for the kind support and help of
- [http://www.southampton.ac.uk/biosci/about/staff/cgp1x07.page Dr. Chris Proud] for providing us with the pGEX-eIF4A of his lab for our experimental use. Dr. Christopher Proud is currently a Professor of Cellular Regulation & Deputy Head of School, Research School of Biological Sciences Life Sciences Building University of Southampton Southampton, UK.
- We thank the campus faculty and students for their suggestions and for their comments on this iGEM project.
- National Yang Ming University and Ministry of Education, Taiwan. This iGEM project is fully supported by them. We wish to acknowledge and thank their supports of this project.
